Chemotherapy for renal cell carcinoma
- PMID: 10768596
Chemotherapy for renal cell carcinoma
Abstract
Renal cell carcinoma is highly resistant to systemic chemotherapy, and no agent should be considered standard in the treatment of metastatic disease. At this time, it is appropriate for patients with advanced local or metastatic renal cell carcinoma to be offered new therapeutic investigational experimental options, since clearly there are limited therapies presently available. The experience with chemotherapy is reviewed.
Similar articles
-
Chemotherapy for renal cell carcinoma.Anticancer Res. 1999 Mar-Apr;19(2C):1541-3. Anticancer Res. 1999. PMID: 10365141 Review.
-
Cytotoxic chemotherapy for advanced renal cell carcinoma.Urol Clin North Am. 1993 May;20(2):303-21. Urol Clin North Am. 1993. PMID: 8493752 Review.
-
Chemotherapy of metastatic renal cancer.Semin Surg Oncol. 1988;4(2):91-4. Semin Surg Oncol. 1988. PMID: 3293156 Review.
-
Survey of chemotherapy of metastatic renal cancer.Semin Surg Oncol. 1988;4(2):87-90. Semin Surg Oncol. 1988. PMID: 3293155 Review.
-
Treatment of recurrent or metastatic renal cell carcinoma.Expert Rev Anticancer Ther. 2004 Dec;4(6):1069-80. doi: 10.1586/14737140.4.6.1069. Expert Rev Anticancer Ther. 2004. PMID: 15606334 Review.
Cited by
-
Systemic therapy for metastatic renal cell carcinoma: a review and update.Rev Urol. 2012;14(3-4):65-78. Rev Urol. 2012. PMID: 23526579 Free PMC article.
-
Interferon-alfa in the treatment of patients with inoperable locally advanced or metastatic renal cell carcinoma: a systematic review.Can Urol Assoc J. 2010 Jun;4(3):201-8. doi: 10.5489/cuaj.853. Can Urol Assoc J. 2010. PMID: 20514286 Free PMC article.
-
Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell carcinoma: a prospective evaluation.Eur J Med Res. 2010;15(7):287-91. doi: 10.1186/2047-783x-15-7-287. Eur J Med Res. 2010. PMID: 20696639 Free PMC article. Clinical Trial.
-
Effects of resveratrol on gene expression in renal cell carcinoma.Cancer Biol Ther. 2004 Sep;3(9):882-8. doi: 10.4161/cbt.3.9.1056. Epub 2004 Sep 21. Cancer Biol Ther. 2004. PMID: 15280659 Free PMC article.
-
Pathway signature and cellular differentiation in clear cell renal cell carcinoma.PLoS One. 2010 May 18;5(5):e10696. doi: 10.1371/journal.pone.0010696. PLoS One. 2010. PMID: 20502531 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical